000790 Chengdu huasun technology group Inc., LTD.
- 3.62
- +0.05+1.40%
Chengdu huasun technology group Inc., LTD. News
Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ): Indirect controlling shareholder Chengdu Yuanhong completed the shareholding of 9.14 million shares.
On July 19th, GeLonghui reported that Chengdu Huasun Technology Group Inc., Ltd. (stock code: 000790.SZ) announced that the company has recently received a notice from Chengdu Yuanhong, its indirectly-controlled shareholder, regarding the completion of the shareholding plan of Chengdu Huasun Technology Group Inc., Ltd. As of the date of this announcement, the shareholding plan has been completed, and Chengdu Yuanhong has accumulated 9.14 million shares of the company through the Shenzhen Stock Exchange trading system in a centralized bidding trading manner, accounting for 1.47% of the total share capital of the company, with a shareholding amount of approximately RMB 30.0645 million.
Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ) plans to distribute CNY 0.1 per 10 shares in 2023 with ex-rights and ex-dividend on July 26.
Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ) announced that it plans to distribute cash to all shareholders for every 10 shares in 2023...
Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ): Terminates restructuring matters.
Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ) announced that it will hold the thirteenth director's meeting on July 10, 2024, according to the company's announcement...
Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ) has not yet engaged in synthetic biology business.
On June 21, Gelunhui reported that Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ) stated on the investor interactive platform that synthetic biology is a national strategic industry with green and low-carbon features. However, the subsidiaries within the scope of consolidation of the company have not engaged in synthetic biology business.
Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ): Huang Mingliang resigned as CEO and was succeeded by Song Tao.
On June 18th, Gelunhui announced that Chengdu Huasun Technology Group Inc., Ltd.'s board of directors recently received the resignation report of the company's president, Mr. Huang Mingliang, in the form of a written submission. After resigning as president, Mr. Huang Mingliang will continue to serve as the chairman of the board of directors, as well as other relevant positions under the board of directors' specialized committee, to enable strategic planning and business management integration for the company. As of the announcement disclosure date, Mr. Huang Mingliang did not directly hold any company shares. On June 18, 2024, the Thirteenth Board of Directors' Thirteenth Conference of the company approved the Appointment Proposal for the company's President, and Mr. Song Tao was appointed as the company's President.
BT Financial Report Instant Analysis: Chengdu Huasun Technology Group Inc., Ltd.'s Q1 2024: Challenges and Opportunities in Steady Development.
Chengdu Huasun Technology Group Inc., Ltd. (stock code: 000790) is a company that focuses on the pharmaceutical and health industry, dedicating itself to achieving technological innovation and international development within the industry. Despite facing multiple challenges such as the expansion of national and local alliance procurement, fierce market competition, decrease in drug prices, and rise in raw material prices in the pharmaceutical industry in 2023, Chengdu Huasun Technology performed well in the Chinese patent medicine and traditional Chinese medicine decoction piece fields. The income and profits of these sub-industries both achieved year-on-year growth, demonstrating the company's competitive advantage in specific areas. At the policy level, the country has issued a series of policy documents to support the development of the pharmaceutical and health industry, including "the 14th Five-Year Plan."
Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ) holding company, Lingkai Technology, plans to apply for listing on the main board of the Hong Kong Stock Exchange.
Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ) announced that Lingkai Technology Co., Ltd. in Shanghai is a participating company of Hainan Huashen Xingrui Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of the company, and is a national high-tech enterprise.
[BT Financial Report Momentary Analysis] In-depth Analysis of Huashen Technology's 2023 Report: Challenges and Opportunities Coexist
As an enterprise with an important position in the fields of medicine and construction steel structures, Huashen Technology (stock code: 000790) attracted market attention for its business activities in 2023. Over the past year, Huashen Technology has faced multiple challenges such as policy adjustments in the pharmaceutical industry, increased market competition, and rising raw material costs. At the same time, it is also actively seeking transformation and breakthroughs to find new growth points in the midst of change. Judging from balance and liability data, Huashen Technology's total assets increased from 1,677 billion yuan in 2022 to 2,133 billion yuan in 2023, an increase of 27.22%, showing the size of the company
Huashen Technology (000790.SZ): Huashen Steel plans to undertake a professional steel structure subcontract project for the Jiangsu Liansheng Heterojunction (HJT) solar cell production project contracted by Rongji Construction
Gelonghui, May 16, 丨 Huashen Technology (000790.SZ) announced that the company's wholly-owned subsidiary, Sichuan Huashen Steel Structure Co., Ltd. (“Huashen Steel Structure”), intends to undertake the steel structure professional subcontract project for the Jiangsu Liansheng Technology Co., Ltd. heterojunction (HJT) solar cell production project contracted by Emeishan Rongji Construction Co., Ltd. (“Rongji Construction”), and signed the “Jiangsu Liansheng Technology Co., Ltd. Heterogeneous Junction (HJT) Solar Cell Production Project Steel Structure Professional Subcontract” with conditions. 1 billion yuan (tax included ), the final settlement price failed
The indirect controlling shareholders of Huashen Technology (000790.SZ) increased their total shares by 1%
According to the Zhitong Finance App, Huashen Technology (000790.SZ) issued an announcement. As of the disclosure date of this announcement, the implementation period of this increase plan has passed. Chengdu Yuanhong Biotechnology Co., Ltd., the indirect controlling shareholder of the company, has increased its holdings of the company's shares by 6,280,000 shares through centralized bidding transactions through the Shenzhen Stock Exchange trading system, accounting for 1% of the current total share capital of the company, and the total amount paid is about 197636 million yuan. The current plan to increase its holdings has not yet been completed, and Chengdu Yuanhong will continue to increase its holdings in accordance with the holdings increase plan.
We Think You Can Look Beyond Chengdu Huasun Technology Group's (SZSE:000790) Lackluster Earnings
Huasun Technology to Cancel 3.8 Million Repurchased Shares
Huashen Technology (000790.SZ): Net profit of 2.2798 million yuan in the first quarter decreased by 28.96% year-on-year
Gelonghui, April 29 | Huashen Technology (000790.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 179 million yuan, down 18.62% year on year; net profit attributable to shareholders of listed companies was 2.2798 million yuan, down 28.96% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1.9454 million yuan, down 30.92% year on year; basic earnings per share were 0.0036 yuan.
Huashen Technology (000790.SZ): Received a government subsidy of 11.2312 million yuan
Gelonghui, April 1, 丨 Huashen Technology (000790.SZ) announced that on March 29, 2024, Tibet Kangyu Pharmaceutical Co., Ltd., the holding subsidiary of Chengdu Huashen Technology Group Co., Ltd. received a special fund of 11.2312 million yuan to support industries related to revenue, accounting for 27.25% of the company's 2022 audited net profit attributable to shareholders of listed companies
Huashen Technology (000790.SZ): As of March 20, 2024, the number of shareholders of the company was 3,9972
Gelonghui March 29 | Huashen Technology (000790.SZ) said on the investor interactive platform that as of March 20, 2024, the number of shareholders of the company was 39,972.
Huashen Technology (000790.SZ) received an indirect controlling shareholder Chengdu Yuanhong's shares increased by 1%
Huashen Technology (000790.SZ) announced that the company received indirect holding shares of the company on February 7, 2024...
Huashen Technology (000790.SZ): The indirect controlling shareholder plans to increase the company's shares by 30 million yuan to 60 million yuan
Gelonghui, February 5, 丨 Huashen Technology (000790.SZ) announced that the company (hereinafter referred to as the “Company”) received the “Notice Letter on the Plan to Increase the Company's Shares” submitted by Chengdu Yuanhong Biotechnology Co., Ltd. (hereinafter referred to as “Chengdu Yuanhong”), the indirect controlling shareholder of the company on February 5, 2024. Based on confidence in the company's future stable development and recognition of long-term investment value, Chengdu Yuanhong, as the main shareholder, plans to increase the company's shares through centralized bidding transactions or bulk transactions within 6 months from February 6, 2024. The proposed increase in holdings is not less than RMB 30 million, no
Some Chengdu Huasun Technology Group Inc. , LTD. (SZSE:000790) Shareholders Look For Exit As Shares Take 28% Pounding
Investors One-year Losses Continue as Chengdu Huasun Technology Group (SZSE:000790) Dips a Further 14% This Week, Earnings Continue to Decline
Huashen Technology (000790.SZ): Currently, the Shandong Lingkai project team is making every effort to promote project construction and is scheduled to be put into operation in the first half of 2024
Gelonghui December 28 丨 An investor asked Huashen Technology (000790.SZ) on the investor interactive platform, “Has Shandong Lingkai put into production?” The company replied that at present, the Shandong Lingkai project team is making every effort to promote project construction and is scheduled to be put into operation in the first half of 2024.
Analysis
Price Target
No Data
